Changchun High -tech growth hormone powder is included in the Fujian collection list, and the market value evaporates 23 billion in a month

Every time there are rumors, Changchun's high -tech stock price will fall. Since the beginning of last year, the Guangdong Ji Cai will be included in growth hormone products, and Changchun High -tech stock price has plummeted. It was rumored that Zhejiang will also join Ji Cai again. One month, Changchun High -tech market value evaporated more than 23 billion yuan.

A few days ago, the Internet was asking rumors on the Internet, and false rumors brought great impact on the company's stock price. The rumors belong to the rumor, but it is not difficult to see that Ji Cai is like a sword hanging on Changchun's high -tech heads. At the same time, it is closely linked to the money bag of 160,000 shareholders. The Changchun High -tech stock market still spreads tension.

On September 6, the Fujian Medical Insurance Bureau announced the "Fujian Provincial Pharmaceutical Bringing Procurement Documents (Draft for Soliciting Opinions)". The reorganized human growth hormone injections were listed, and the rumors of collecting collection finally landed.

Changchun High -tech stated on the interactive platform that according to the collection notice issued by the Fujian Medical Insurance Bureau, the reorganization of human growth hormone injection (specifications: 4IU, 10IU) corresponds to the company's growth hormone pink needles. , Will actively track the changes in the policy, actively participate in and fully formulate a response plan to ensure the stable growth of the company's performance.

In response to investors' questions, Changchun High -tech stated that he will fully support and actively participate in this drug collection. The subsidiary Golden Pharmaceutical currently has three dosage types: growth hormone powder, water and long -acting, of which the powder is a base. The company's choice of powder for bidding and significantly reduced prices is also the call to respond to the national basic drug policy and medical insurance control.

At present, water has the greatest impact on Changchun's high -tech performance. According to the investor relationship recording form disclosed by Changchun High -tech, the pink needle in Jincai Pharmaceutical's income accounted for only about 10%, the water injection accounted for more than 70%, and the long -term water injection accounted for more than 18%.

Earlier, Guangdong Jicai, Golden Pharmaceutical only declared the specifications of three types of powder needles, with a price reduction of about 25%. The growth hormone incorporated in Fujian collection corresponds to Changchun High -tech growth hormone pink needles. Compared with the collection of water pins, the impact of pink needle collection on Changchun High -tech is small, the price has decreased, and it may also expand in the hospital in the hospital. market share.

How Changchun High -tech will be deserved to pay attention to this Fujian collection. After the confirmation of Ji Cai, on September 7, Changchun High -tech stock price fell 3.81%to 167.88 yuan per share.

(Author | Naimu)

- END -